CCI Welcomes Response Biomedical to Our National Network of Innovators

The Council of Canadian Innovators is delighted to announce that Response Biomedical has joined our national network of leading technology companies.

Based in Vancouver, British Columbia, Response Biomedical is at the forefront of medical technology with their revolutionary RAMP® system. This rapid diagnostics platform provides lab-quality performance, ensuring efficient patient management in acute care settings. Under the leadership of CEO Dr. Barb Kinnard, Response Biomedical develops, manufactures, and markets these innovative diagnostic solutions that are critical in accelerating and improving patient care.

"Response Biomedical is dedicated to transforming patient management through rapid and reliable diagnostic technology," said CEO Dr. Barb Kinnard. "Our RAMP® system is designed to deliver immediate, precise results, enabling healthcare professionals to make quicker, more informed decisions."

Benjamin Bergen, President of the Council of Canadian Innovators, said, "We are proud to welcome Response Biomedical to the CCI family. Their work epitomizes the kind of innovation and leadership in technology that CCI aims to support. Dr. Kinnard and her team are making significant contributions to healthcare, enhancing patient outcomes across Canada and beyond."

Since 2015, the Council of Canadian Innovators has been committed to supporting high-growth Canadian-headquartered technology companies and advocating for policies that unlock the nation’s innovation potential.

‍